Silver Touch Technologies' subsidiary, Ai4Pharma Tech Limited, has launched its first AI-driven product, "ChatGMP", a pharmaceutical domain-trained conversational platform based on Generative AI technology.
ChatGMP is designed exclusively for pharmaceutical teams working in GMP-regulated environments, understanding pharma language and compliance needs unlike generic chatbots.
Key features of ChatGMP include:
Comprehensive Data Access: Aggregates data from FDA sources, competitor profiles, and compliance records.
Smart Query Functionality: Understands complex queries like "What were the top FDA 483 observations in the last year for sterile facilities?"
Versatile Data Analysis: Identifies trends, flags risks, and compares competitor performance.
Time Efficiency: Automates data gathering and simplifies analysis for faster decision-making.
Mr. Amish Vyas, Co-Founder & CEO at Ai4Pharma, stated that ChatGMP marks a significant milestone in using AI for better Pharma outcomes, streamlining communication and upholding accuracy and compliance.